{"id":1880,"date":"2020-04-09T16:31:30","date_gmt":"2020-04-09T15:31:30","guid":{"rendered":"https:\/\/healthcareers.co\/?p=1880"},"modified":"2020-06-20T23:42:20","modified_gmt":"2020-06-20T22:42:20","slug":"alzheimers-disease-statistics","status":"publish","type":"post","link":"https:\/\/healthcareers.co\/alzheimers-disease-statistics\/","title":{"rendered":"31 Unforgettable Alzheimer&#8217;s Disease Statistics"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">For more than a century, scientists have been struggling to understand the exact causes of this fatal neurodegenerative disease. Fortunately, they have made some progress in this direction. These <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s disease statistics<\/span><span style=\"font-weight: 400;\"> attest to the numerous studies and observations dedicated to this prevalent and dreadful impairment.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Around 50 million people worldwide will be diagnosed with Alzheimer\u2019s disease by 2025, especially those older than 65, since advanced age is the biggest known risk factor. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">With its effects of gradual dehumanization and a slow, progressive neurological demise, Alzheimer\u2019s disease horrifies many, especially those in the developed countries, where both awareness and prevalence concerning Alzheimer\u2019s disease are high.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, being informed can help you identify the signs and <\/span><span style=\"font-weight: 400;\">symptoms of Alzheimer\u2019s<\/span><span style=\"font-weight: 400;\"> disease and, consequently, reach an early self-diagnosis or diagnose a loved one, which, in turn, can significantly improve the life quality of life of the affected.\u00a0<\/span><\/p>\n<h2><b>The Top 10 <\/b><b>Alzheimer\u2019s Disease Statistics<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Alzheimer\u2019s dementia is the 6th leading cause of death in the US.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">There was a 213% rise in dementia-related deaths during the period 2000\u20132017.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">1 in 3 patients aged 59\u201375 dies within 5 years after being diagnosed with Alzheimer\u2019s disease.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Racial disparities in Alzheimer\u2019s prevalence amongst blacks and whites are slowly disappearing.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">32% of the people older than 65 with mild cognitive impairment will develop Alzheimer\u2019s in the next 5 years.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Animal studies show a possible connection between gut bacteria and beta-amyloid plaque formation in the brain.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Brain changes can be present for 22 years before the onset of <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s symptoms<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">50% of the people with Down syndrome have Alzheimer\u2019s dementia in their 60s.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">55% of Americans that are aware of their cognitive decline don\u2019t consult with a physician.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">There are 102 clinical trials aimed at modifying Alzheimer\u2019s disease.<\/span><\/li>\n<\/ul>\n<h2><b>Prevalence and Mortality of <\/b><b>Alzheimer\u2019s Disease<\/b><\/h2>\n<hr \/>\n<h3><b>1. Around 7.1 million Americans over 65 will develop Alzheimer\u2019s dementia by 2025.\u00a0<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Alzheimer\u2019s Association)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The statistics concerning the incidence of Alzheimer\u2019s saw an increase of 27% between 2019\u20132020. Around 7.1 individuals over 65 will develop Alzheimer\u2019s by 2025, and the total number will reach 13.8 million by 2050.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The <\/span><a href=\"https:\/\/healthcareers.co\/retirement-stats\/\"><span style=\"font-weight: 400;\">retirement of the baby-boom generation<\/span><\/a><span style=\"font-weight: 400;\"> will increase the percentage of the old population to 20% by 2030, counting some 74 million people over 65. Around 3 million of those affected by Alzheimer\u2019s disease will be older than 85 by 2031.\u00a0<\/span><\/p>\n<h3><b>2. <\/b><b>Alzheimer\u2019s disease statistics<\/b><b> in the US f<\/b><b>or <\/b><b>2019<\/b><b> reveal that the state of California has the highest number of patients.\u00a0<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Alzheimer\u2019s Association, Statista)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Currently, Alzheimer\u2019s affects 5.7 million of the US population older than 65, or 5.8 million when counting all age groups. Estimations show that every 65 seconds, an American develops the <\/span><span style=\"font-weight: 400;\">symptoms of Alzheimer\u2019s<\/span><span style=\"font-weight: 400;\"> disease.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In 2019, the most significant number of patients was recorded in California, where 670,000 of the population older than 65 were diagnosed with Alzheimer\u2019s. Next in line were Florida (560,000), New York (400,000), and Texas (390,000). Alaska, the District of Columbia, and Wyoming have the smallest numbers of people diagnosed with Alzheimer\u2019s.<\/span><\/p>\n<h3><b>3.<\/b> <b>Dementia statistics<\/b><b> in<\/b><b> the <\/b><b>United States<\/b><b> for <\/b><b>2018<\/b><b> rate Alzheimer\u2019s dementia as the 6th leading cause of death.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Statista)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The age-adjusted data for the top 10 leading causes of death among Americans shows that Alzheimer\u2019s disease is in the sixth place, after heart disease, <\/span><a href=\"https:\/\/healthcareers.co\/cancer-statistics\/\"><span style=\"font-weight: 400;\">cancer<\/span><\/a><span style=\"font-weight: 400;\">, COPD, accidents, and strokes, but preceding <\/span><a href=\"https:\/\/healthcareers.co\/diabetes-statistics\/\"><span style=\"font-weight: 400;\">diabetes<\/span><\/a><span style=\"font-weight: 400;\">, respiratory infections, suicide, and nephritis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In 2018, Alzheimer\u2019s disease was responsible for 30.5 deaths per 100,000 of the US population. Alzheimer\u2019s dementia was also named third on the list of the 10 leading causes of death among the upper-income countries for 2016.<\/span><\/p>\n<h3><b>4. Finland has the highest dementia-related death rate, according to <\/b><b>Alzheimer\u2019s statistics worldwide<\/b><b>.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(World Life Expectancy)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Following statistical data from the World Health Organization for 2017, the highest death rate due to Alzheimer\u2019s and other types of dementia is recorded in Finland, where there were 65.70 recorded dementia and Alzheimer\u2019s deaths per 100,000 population.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Following Finland were Kuwait, Turkey, and Saudi Arabia, with 58.17, 51.11, and 49.94 deaths per 100,000, respectively. The US was ranked eighth, with 44.41 deaths per 100,000 population. In 2017, countries with the lowest death rates due to Alzheimer\u2019s and other dementia were Singapore, Kyrgyzstan, and the Philippines.\u00a0<\/span><\/p>\n<h3><b>5. <\/b><b>Dementia statistics<\/b><b> for the period 2000\u20132017 expose a 213% rise in dementia-related deaths.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Science Direct, Statista)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">US statistics for 2017 counted almost 262,000 deaths that had dementia as an underlying cause, out of which 121,404 of them were due to Alzheimer\u2019s disease. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Over the course of seven years, the US figures for dementia deaths had shown a staggering increase in the death toll since the year 2000, when there were 83,694 deaths attributed to dementia. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">The calculated difference of 178,220 new deaths represents an increase of almost 213% over the period 2000\u20132017, whereas Alzheimer\u2019s death toll increased by 145%.<\/span><\/p>\n<h3><b>6. <\/b><b>Alzheimer\u2019s disease facts and figures<\/b> <b>showed that, <\/b><b>in<\/b> <b>2017,<\/b><b> Vermont had the highest Alzheimer\u2019s death toll in the US.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Statista)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A survey conducted in 2017 showed that, in that year, Vermont recorded 59.3 deaths caused by Alzheimer\u2019s per 100,000 of the population, making it the state with the biggest number of Alzheimer\u2019s deaths for 2017.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Following Vermont was Mississippi, with 54.5 deaths per 100,000 population. Alabama, Tennessee, and North Dakota were next, with death rates of 52.6, 52.4, and 51.2 per 100,000, respectively. On the other hand, New York State counted the lowest number of Alzheimer-related deaths (43 per 100,000 of the population).<\/span><\/p>\n<h3><b>7. <\/b><b>Alzheimer\u2019s disease statistics<\/b><b> confirm that 1 in 3 patients aged 59\u201375<\/b> <b>dies within 5 years after being diagnosed.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(BioMedCentral, JHSPH)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Results from a 2002 study show that the median survival rate for patients with Alzheimer\u2019s is\u00a0 8.3 years for those diagnosed at 65, and it\u2019s 3.4 years for those diagnosed at the age of 90. However, individual factors may contribute to a slower or more rapid decline of the disease and modify these expectations.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Another study found that 35% of those aged 59\u201375 died five years after their diagnosis. The biggest risk factors were shown to be old age, male gender, high presence of biomarkers, and severe cognitive impairment, excluding comorbidities.<\/span><\/p>\n<h2><b>Alzheimer\u2019s Disease Statistics<\/b><b> by <\/b><b>US Demographics\u00a0<\/b><\/h2>\n<hr \/>\n<h3><b>8. 81% of Americans suffering from Alzheimer\u2019s disease are 75 or older.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Science Direct)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In 2019, there were 5.8 million Americans diagnosed with Alzheimer\u2019s disease. The biggest share of patients (81%) belonged to the age group of 75 or older. The smallest percentage of approximately 3% were people younger than 65, classified as individuals with early-onset of Alzheimer\u2019s disease (EOAD).\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">16% of those struggling with Alzheimer\u2019s were in the age group 65\u201374 years, representing some 900,000 individuals. A staggering 2.6 million Americans aged 75\u201384 (or 45%) were diagnosed with Alzheimer\u2019s disease, and another 36% of the total number of patients were individuals older than 85.\u00a0<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">\u00a0<\/span><b>9. <\/b><b>Alzheimer\u2019s disease stats<\/b><b> show that the racial disparities in prevalence amongst blacks and whites are slowly disappearing.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(NCBI, Science Direct)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A scientific article published in 2018 showed that, when it comes to the prevalence of Alzheimer\u2019s, racial disparity amongst the blacks and whites in America is declining. Today, this ratio is 1.5:1.5 as opposed to 2:1 in 2004.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, the racial difference in dementia incidence is growing between the Hispanic population and the white population (2:1). There is a strong suspicion that these differences are even bigger because missed diagnosis is more common for ethnic minorities than in whites.<\/span><\/p>\n<h3><b>10. <\/b><b>Alzheimer\u2019s disease facts<\/b><b> state that women have a slightly higher chance of developing this disease.\u00a0<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Statista)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to the 2015 estimations, women have a slightly higher risk of developing this disease. Following statistical data, American men aged 45 have a 10.3% risk of developing Alzheimer\u2019s in their lifetime, while women of the same age have an 11.6% chance of sharing the same fate.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The same correlation is observed in those older than 65, where men presented 19.5% chances of being diagnosed with Alzheimer\u2019s, whereas women aged 65 years and over had 21.1% risk of developing this disease.<\/span><\/p>\n<h3><b>11. In <\/b><b>2019, Alzheimer\u2019s disease facts and figures<\/b><b> revealed that 32% of the people older than 65 with mild cognitive impairment would develop Alzheimer\u2019s in 5 years.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Alzheimer\u2019s Association)\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A study published in the 2019 report of the Alzheimer\u2019s Association shows that 15\u201320% of the US population aged over 65 has a mild cognitive impairment (MCI) of any cause. One study showed an increased risk for these demographics to develop Alzheimer\u2019s or other dementias. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Namely, after a 2-year follow-up, 15% of these individuals developed dementia. The analysis of a bigger poll of studies showed that 32% of Americans over 56 with MCI developed Alzheimer\u2019s dementia within five years.\u00a0<\/span><\/p>\n<h3><b>12. <\/b><b>Statistics on Alzheimer\u2019s<\/b><b> reveal that around 200,000 people aged 30\u201360 in the US struggle with early-onset Alzheimer\u2019s.\u00a0<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(NCBI, Science Direct)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A 2016 survey discovered that figures for the early-onset Alzheimer\u2019s disease (EOAD) are much higher than the previously thought, 1\u20132%, and go along the lines of 5.5% of the total number of cases. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">A meta-analysis that included 13 papers noted a prevalence of 5.9% of EOAD in the developed countries and 4.4% in the developing countries. In the US, around 200,000 people had an early onset of Alzheimer\u2019s disease in 2019, representing roughly 3% of the total numbers.<\/span><\/p>\n<h3><b>13. <\/b><b>Alzheimer\u2019s disease statistics<\/b><b> confirm that people with higher formal education have lower chances of developing Alzheimer\u2019s and other dementias.\u00a0<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Alzheimer\u2019s Association)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Having a longer formal education is beneficial to the so-called cognitive reserve. Connections between neurons are stronger in people who are stimulated by cognitive tasks. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">This enables for better plasticity or adaptability of the brain tissue, which, even when affected by Alzheimer\u2019s, can compensate and slow down cognitive decline. Other risk factors in correlation to formal education are the socio-economic status, which plays a big role in the onset of many diseases, including Alzheimer\u2019s and other dementias.<\/span><\/p>\n<h2><b>Alzheimer\u2019s Disease Statistics<\/b><b>: Risks Fac<\/b><b>tors<\/b><\/h2>\n<hr \/>\n<h3><b>14. Animal studies show a possible connection between gut bacteria and beta-amyloid plaque formation in the brain.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Science Daily)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A 2017 research at Lund University found a connection between plaques formation \u2014 a typical process characteristic for the <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s brain<\/span><span style=\"font-weight: 400;\"> and the gut bacteria in mice. This study observed the gut flora (the composition of different types of bacteria) of mice with Alzheimer\u2019s disease and healthy mice.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Researchers concluded that certain gut bacteria were directly involved in beta-amyloid plaque formation in the brain, and if they were transferred to the healthy mice, they will, in turn, develop these brain malformations. However, further studies are needed to confirm these findings in humans.<\/span><\/p>\n<h3><b>15. <\/b><b>Interesting facts about Alzheimer\u2019s<\/b><b> show that ex-professional football players have a 5 times higher risk of developing this disease.\u00a0<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Medical News Today)\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A long-term study, including 7,676 ex-professional footballers, showed that they had a 3.5 times higher chance of dying of nerve or brain damage than other populations. Researchers believe that this statistic is most certainly due to repeated head trauma when heading the heavy leather ball.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Consequently, goalkeepers were 59% less likely to be diagnosed with the disease than footballers. The risk of developing Alzheimer\u2019s among football players was found to be five times higher than in other populations.\u00a0<\/span><\/p>\n<h3><b>16. Benzodiazepines were linked to a 30% increased risk of pneumonia in patients wit<\/b><b>h <\/b><b>Alzheimer\u2019s disease, facts<\/b><b> in a scientific study show.\u00a0<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Science Daily)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Research published in the Canadian Medical Association Journal concludes that popular sedatives such as benzodiazepines, which are used in managing the symptoms of Alzheimer\u2019s disease can be a risk factor for these patients to develop pneumonia.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The research comparing the data for pneumonia incidence and the use of Z-drugs (non-benzodiazepines) and benzodiazepines in participants with a median age of 80, showed that benzodiazepines increase the risk of pneumonia by 30%. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">This is most probably due to the increasing aspiration of food or saliva into the lungs caused by the sedative effect of these drugs in Alzheimer\u2019s patients.\u00a0\u00a0<\/span><\/p>\n<h3><b>17. <\/b><b>Facts about Alzheimer\u2019s disease<\/b><b> show that 50% of people with Down syndrome have Alzheimer\u2019s dementia in their 60s.\u00a0<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Alzheimer\u2019s Association)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Individuals with Down syndrome are more likely to develop Alzheimer\u2019s than the rest of the population. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">This is because the chromosome 21 (which is present in three copies in these individuals instead of two) is responsible for the synthesis of the Alzheimer\u2019s-related protein that accumulates as plaques in the so-called \u201c<\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s brain<\/span><span style=\"font-weight: 400;\">.\u201d\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">By their 40s, most people with Down syndrome have accumulated high amounts of beta-amyloid in their brains. Hence 30% of them in their 50s and 50% in their 60s will develop Alzheimer\u2019s dementia.<\/span><\/p>\n<h3><b>18. <\/b><b>Facts on Alzheimer\u2019s disease<\/b><b> show that sleep apnea is closely linked to the onset of Alzheimer\u2019s.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(AARP)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In a recent study, 43% of the surveyed 288 individuals older than 65, with no symptoms of cognitive impairment, were subject to brain analysis due to reported <\/span><a href=\"https:\/\/healthcareers.co\/sleep-statistics\/\"><span style=\"font-weight: 400;\">sleep apnea<\/span><\/a><span style=\"font-weight: 400;\">. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">The results showed that in all of the investigated subjects, the levels of proteins related to Alzheimer\u2019s were higher for 4.5% in the part of the brain that is related to memory.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Another research conducted in 2017 confirmed these results, adding that the concentration of the Alzheimer\u2019s biomarkers (specific proteins) was proportionate to the severity of the sleep apnea.<\/span><\/p>\n<h2><b>Alzheimer\u2019s Disease<\/b><b> Diagnosis\u00a0<\/b><\/h2>\n<hr \/>\n<h3><b>19. 55% of Americans that are aware of their cognitive decline don\u2019t consult with a physician.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Science Direct)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A 2015\u20132016 survey showed that 11% of Americans aged 45 and older reported experiencing a cognitive decline. However, only 45% of these individuals scheduled a medical consultation for this symptom.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Since <\/span><a href=\"https:\/\/healthcareers.co\/alcoholism-statistics\/\"><span style=\"font-weight: 400;\">alcohol consumption<\/span><\/a><span style=\"font-weight: 400;\">, sleep apnea, depression, thyroid problems, and certain medications can provoke symptoms similar to those of dementia, not everyone who subjectively observes a decline in his mental capacities will develop MCI or Alzheimer\u2019s, but statistics show that a big percent of them do. Hence, consulting a professional is always a good choice.<\/span><\/p>\n<h3><b>20.<\/b> <b>Facts about Alzheimer\u2019s<\/b><b> confirm that it can be detected early on by the simple means of cognitive tests.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Science Daily)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Alzheimer\u2019s disease is usually detected by PET scanning and analysis of the cerebrospinal fluid of the patients that present the typical <\/span><span style=\"font-weight: 400;\">signs of Alzheimer\u2019s.<\/span><span style=\"font-weight: 400;\"> However, these methods are invasive, expensive, and inaccessible for many.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Early detection is crucial for a better prognosis, and scientists found out that this can be done by assessing cognition decline. The results of the meta-analysis of 61 studies showed that specific cognition tests could be an indicator of the onset of Alzheimer\u2019s if a basic cognition test result is obtained previously for comparison.<\/span><\/p>\n<h3><b>21. Recent <\/b><b>Alzheimer\u2019s facts<\/b><b> show that brain changes can be present for 22 years before the onset of <\/b><b>Alzheimer\u2019s disease symptoms<\/b><b>.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Alzheimer\u2019s Association)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A 2018 study showed that in the case where a rare genetic mutation inevitably leads to Alzheimer\u2019s, the indicators of the existence of the disease could be found as early as 22 years before the onset of any of the <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s symptoms<\/span><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In these individuals, and probably all other cases of Alzheimer\u2019s, there is a longer preclinical stage of the disease than previously thought, during which the brain manages to compensate for the damaged and dead neurons. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">The glucose metabolism decline can begin 18 years prior to the onset of symptoms, and the typical atrophy or the <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s brain<\/span><span style=\"font-weight: 400;\"> can be detected 13 years prior to that.\u00a0<\/span><\/p>\n<h3><b>22. <\/b><b>Alzheimer\u2019s facts and figures<\/b><b> show that 30% of patients with clinical <\/b><b>Alzheimer\u2019s symptoms<\/b><b> don<\/b><b>\u2019t have Alzheimer\u2019s-related dementia.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Science Direct)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Currently, researchers are working towards providing a so-called biomarker-based data for Alzheimer\u2019s disease prevalence that should give significantly different estimates than the ones we have. Biomarkers are the morphological and chemical changes that are present in patients.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Recent research found that as much as 30% of people with normal cognition can test positive for Alzheimer\u2019s biomarkers. In contrast to this, the autopsy of some 30% of people who died due to clinical-symptoms diagnosed with Alzheimer\u2019s dementia didn\u2019t have the necessary brain atrophy related to Alzheimer\u2019s, so their dementia was not caused by Alzheimer\u2019s disease.<\/span><\/p>\n<h3><b>23. <\/b><b>Alzheimer\u2019s disease symptoms<\/b><b> go undiagnosed for an average of 1.5 years.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(SciELO)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A 2011 study found that the median time delay from the onset of <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s symptoms<\/span><span style=\"font-weight: 400;\"> to diagnosis was 1.5 years. For 36% of patients, family members believed that memory-related troubles were a normal part of the process of aging and this delayed diagnosis for 1.8 years. In contrast, in 45.3% of cases, the delay happened due to a physician\u2019s inability to reach a diagnosis.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Patients with Alzheimer\u2019s consulted two doctors on average prior diagnosis, but some had multiple visits to three or more physicians delaying the time of diagnosis for 1.5, 1.7, and 3.2 years, respectively.\u00a0<\/span><\/p>\n<h3><b>24. Behavioral <\/b><b>Alzheimer\u2019s disease symptoms<\/b> <b>like depression, anxiety, and aggression are more common in younger patients.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">\u00a0(NCBI)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It is widely known that <\/span><a href=\"https:\/\/healthcareers.co\/stroke-statistics\/\"><span style=\"font-weight: 400;\">memory loss<\/span><\/a><span style=\"font-weight: 400;\"> is one of the first telltale <\/span><span style=\"font-weight: 400;\">signs of Alzheimer\u2019s<\/span><span style=\"font-weight: 400;\"> disease, but recent research shows that in younger patients, other symptoms like visuospatial problems, social withdrawal, or poor judgment can precede memory-loss as a symptom of this disease.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A 2015 study found that, in 26% of the Alzheimer patients that were younger than 60, the first symptom was not memory-related. In comparison, in patients older than 70, this study found that only 8% had other non-memory related symptoms of Alzheimer\u2019s that preceded the memory loss.<\/span><\/p>\n<h2><b>Treatment of <\/b><b>Alzheimer\u2019s Disease: Facts and Figures<\/b><b>\u00a0<\/b><\/h2>\n<hr \/>\n<h3><b>25. US statistics for 2018 show an average lifetime healthcare charge of $350,174 per person with Alzheimer\u2019s dementia.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Science Direct)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A group of researchers calculated the average cost of lifetime care for Americans with Alzheimer\u2019s dementia. It includes the out-of-pocket costs, Medicaid, and Medicare, as well as the worth of the informal caregiving for 2018, at $350,174 per person with dementia.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Due to gender differences of prevalence, and life expectancy, the Medicaid expenditures were estimated as 70% greater for female patients. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">What\u2019s more, the additional charge that individuals with Alzheimer\u2019s face, when compared with the population with other diseases and comorbidities, was estimated at $199,871 for 2018.\u00a0<\/span><\/p>\n<h3><b>26. <\/b><b>Alzheimer\u2019s statistics worldwide<\/b> <b>in <\/b><b>2018<\/b><b> show that there are 102 clinical trials aimed at modifying this disease.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(AlzDiscovery, Alzheimer\u2019s Association)\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">There have been 100 attempts for <\/span><a href=\"https:\/\/healthcareers.co\/pharmaceutical-statistics\/\"><span style=\"font-weight: 400;\">effective drug treatment<\/span><\/a><span style=\"font-weight: 400;\"> of Alzheimer\u2019s since 1998, and only four officially approved medications. Clinical trial data in 2018 showed that there were over 220 active clinical studies regarding Alzheimer\u2019s disease that included pharmacological and non-pharmacological treatments, as well as analysis of diagnostic agents for PET scans.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As much as 102 of the trials were aimed at pharmacological modification of Alzheimer\u2019s, out of which 15 for drugs focused on addressing symptoms and 14 were prevention drugs. In 2018, there were 17 drugs in phase three of clinical trials.<\/span><\/p>\n<h3><b>27. There were 18,505 million hours of unpaid care for people with dementia in <\/b><b>2018, Alzheimer\u2019s disease facts and figures<\/b><b> reveal.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Statista)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Patients struggling with Alzheimer\u2019s and other forms of dementia in the higher stage are in need of progressively bigger medical care and help in their daily activities. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Often, the responsibility of caring for such a person falls on the close family members who are helping out with unpaid assistance and care that reached around 18,505 million hours in 2018.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This year, there were approximately <\/span><a href=\"https:\/\/healthcareers.co\/\"><span style=\"font-weight: 400;\">16.25 million caregivers<\/span><\/a><span style=\"font-weight: 400;\"> for people with Alzheimer\u2019s disease and other types of dementia. The estimated value of their non-paid work was $234 billion in 2018.\u00a0<\/span><\/p>\n<h3><b>28. <\/b><b>Dementia statistics<\/b><b> show that two-thirds of caregivers are wives, and one-third are daughters of dementia patients.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">\u00a0(Science Direct)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Statistics show that over two-thirds of people who look after people with dementia are women. As shown by the results of a 2014 survey, 67% of those who provided care superior to 20 hours per week were women.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Furthermore, a 2016 survey confirms that 73% of those who cared for a loved one who has dementia for more than 40 hours per week were women. Women are also two and a half times more likely to live together with the dementia-affected individual and care for them for five years or more.<\/span><\/p>\n<h3><b>29. <\/b><b>Statistics of Alzheimer\u2019s disease<\/b><b> for 2014 show that 40% of the people in residential care were diagnosed with this disease in the US.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Statista)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Statistical data obtained by a survey of 835,200 US patients in <\/span><a href=\"https:\/\/healthcareers.co\/nursing-statistics\/\"><span style=\"font-weight: 400;\">residential care<\/span><\/a><span style=\"font-weight: 400;\"> was used to explore the most frequent diagnosis among the Americans in residential care in 2014. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">The results showed that 40% of them were struggling with Alzheimer\u2019s disease, making it the second most frequent diagnosis amongst the residential population after cardiovascular diseases. The patients with Alzheimer\u2019s dementia were frequently placed in little communities of 4\u201325 beds, and rarely in large residential communities of over 50 beds.<\/span><\/p>\n<h3><b>30. Regular mental activity can lead to a 2.6 times reduction in the chances of developing <\/b><b>dementia, facts<\/b><b> in a recent research show.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(Science Daily)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A study involving over 700 individuals with an average age of 80 conducted with yearly cognitive testing, showed that individuals who stayed cognitively active had a 2.6 times lower risk of developing Alzheimer\u2019s disease and other dementias.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The activities in question were in the ranks of visiting a library or attending a play, reading a newspaper, playing chess, or engaging in other mentally stimulating activities. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">All of these activities needed to be exercised regularly to maintain a decent cognitive level and to lower the rates of dementia in the older population.<\/span><\/p>\n<h3><b>31. <\/b><b>Alzheimer\u2019s stats<\/b><b> show that regular aerobic exercise can slow down Alzheimer\u2019s-related dementia.<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">(CNN)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A study involving 70 participants older than 55 with mild cognitive impairment revealed that regular <\/span><a href=\"https:\/\/healthcareers.co\/exercise-statistics\/\"><span style=\"font-weight: 400;\">aerobic exercise<\/span><\/a><span style=\"font-weight: 400;\"> could slow down the decline in cognitive capacity of people with a high risk of developing Alzheimer\u2019s.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The training, which lasted 12 months, included aerobic exercise and stretching, and revealed that aerobic exercises had a better impact on the preservation of cognitive functions. A significant reduction in shrinkage of the hippocampal brain region that is responsible for memory was noted in this study, indicating slower atrophy of the brain.<\/span><\/p>\n<hr \/>\n<h2><b>FAQ<\/b><\/h2>\n<h3><b>What are the 10 warning signs of Alzheimer\u2019s disease?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Some of the most common <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s symptoms<\/span><span style=\"font-weight: 400;\"> are the following:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Memory loss that poses problems in the normal daily functioning of the individual, particularly forgetting recently learned information.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Difficulties in planning and solving problems, particularly following tasks that involve numbers and counting.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Struggling or taking the time that is longer than usual to complete a familiar task or find the path to a familiar place.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Confusing the dates and having no time orientation.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Having troubles with understanding visual-spatial relationships in images is another one of the most frequent <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s disease symptoms<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Encountering difficulties to finish a sentence or find the correct word.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Being unable to find things because of the inability to retrace steps or because of misplacing the object.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Poor decision making, such as spending too much money or not taking care of personal hygiene.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Social isolation because of the inability to follow a conversation and disrupting favorite hobbies because of the inability to remember how to perform them correctly.\u00a0\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Personality changes towards anxious and disproportionate responses when someone or someplace is not familiar.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">\u00a0The frequency and severity of the symptoms are in relation to the different <\/span><span style=\"font-weight: 400;\">stages of Alzheimer\u2019s<\/span><span style=\"font-weight: 400;\"> disease.<\/span><\/p>\n<h3><b>What percentage of people 85 and older have Alzheimer\u2019s disease?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Around 36% of the people aged 85 and over in the US have Alzheimer\u2019s disease. This percentage is expected to reach 40\u201350% when the baby-boomers reach this age. Global statistics from 2005 estimate that around 20\u201325% of the global population over 85 has Alzheimer\u2019s.<\/span><\/p>\n<h3><b>When does Alzheimer\u2019s start?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">The average onset age for <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s symptoms<\/span><span style=\"font-weight: 400;\"> is around the age of 65, but the median time needed to reach a diagnosis is around 2.8 years. In the US, the vast majority of diagnosed Alzheimer patients are 75 or older (81%). Statistical data reveals that one in every 10 Americans aged over 65, and one in three aged over 85 have Alzheimer\u2019s.<\/span><\/p>\n<h3><b>How common is Alzheimer\u2019s?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">The WHO estimates that there are around 44 million people affected by Alzheimer\u2019s. However, this disease is expected to affect 81 million people globally by 2040. The US counted 5.8 million people with Alzheimer\u2019s in 2019.\u00a0<\/span><\/p>\n<h3><b>When was Alzheimer\u2019s discovered?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Alzheimer\u2019s disease was discovered on November 3, 1906, by the German clinical psychiatrist and neuroanatomist Alois Alzheimer following the case of a 50-year woman called Auguste D. Dr. Alzheimer described her symptoms as progressive <\/span><a href=\"https:\/\/healthcareers.co\/insomnia-statistics\/\"><span style=\"font-weight: 400;\">sleep disturbance<\/span><\/a><span style=\"font-weight: 400;\">, memory loss, paranoia, and aggression. After her death, he discovered the typical morphology (plaques) of what is later to be known as <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s brain<\/span><span style=\"font-weight: 400;\">. He also examined three other cases of this disease and described the different <\/span><span style=\"font-weight: 400;\">stages of Alzheimer\u2019s<\/span><span style=\"font-weight: 400;\"> as with and without plaques.<\/span><\/p>\n<h3><b>What are the 7 stages of Alzheimer\u2019s?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Today, the experts recognize three large <\/span><span style=\"font-weight: 400;\">stages of Alzheimer\u2019s disease,<\/span><span style=\"font-weight: 400;\"> such as preclinical phase, mild cognitive impairment (MCI), and dementia. The last two are further divided into very mild and mild changes; and mild, moderate, severe, and very severe decline.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In the first stage, patients have the bio-indicators such as structural changes in the brain, along with the molecules that indicate the presence of Alzheimer\u2019s in the blood and cerebrospinal fluid, but the typical Alzheimer\u2019s-related symptoms such as memory loss are still absent. In contrast, in the other six <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s stages<\/span><span style=\"font-weight: 400;\">, symptoms are present to various degrees that progress along with the stages of the disease.<\/span><\/p>\n<h3><b>What is the largest risk factor for Alzheimer\u2019s disease?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Even though the exact <\/span><span style=\"font-weight: 400;\">causes of dementia<\/span><span style=\"font-weight: 400;\"> due to Alzheimer\u2019s are not yet known, the most significant evident risk factor for this disease is the increase of age. <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s facts<\/span><span style=\"font-weight: 400;\"> also point to family history as a risk factor, which can indicate a genetic predisposition or environmental factor. Other potential contributors to developing Alzheimer\u2019s are head injuries and any kind of cardiovascular illness, including <\/span><a href=\"https:\/\/healthcareers.co\/stroke-statistics\/\"><span style=\"font-weight: 400;\">stroke<\/span><\/a><span style=\"font-weight: 400;\">, heart disease, and high blood pressure.<\/span><\/p>\n<h3><b>How long can you live with Alzheimer\u2019s?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Even though <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s cure<\/span><span style=\"font-weight: 400;\"> does<\/span><span style=\"font-weight: 400;\">n\u2019t exist yet, modern medicine has put in place <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s treatment<\/span><span style=\"font-weight: 400;\"> that may slow down the progression of symptoms. The average life expectancy after diagnosis ranges from four to eight years, and some people can live up to 20 years with this disease if the symptoms progress slowly. The individual factor plays a big role in Alzheimer\u2019s prognosis, but there might also be other factors that are not yet known in modern medicine.<\/span><\/p>\n<hr \/>\n<h2><b>Conclusion<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">The aging of the baby-boom generation puts enormous pressure on science to find an effective solution to Alzheimer\u2019s disease. Over the years, over a hundred substances deemed useful in the treatment of Alzheimer\u2019s have failed, leaving us with a handful of medicines which, unfortunately, do not affect the progress of this disease. However, scientists claim that we\u2019re a step away from finding a more effective way to prevent and treat this disease, which, following <\/span><span style=\"font-weight: 400;\">Alzheimer\u2019s disease statistics<\/span><span style=\"font-weight: 400;\">, will save many human lives and preserve economies across the globe.\u00a0<\/span><\/p>\n<h3><b>Sources:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.aarp.org\/health\/conditions-treatments\/info-2019\/sleep-apnea-alzheimers-link.html\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">AARP<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.alzdiscovery.org\/assets\/content\/static\/clinical-trials-report-2018.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">AlzDiscovery<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.alz.org\/media\/documents\/alzheimers-facts-and-figures-2019-r.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Alzheimer\u2019s Association<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.alz.org\/alzheimers-dementia\/facts-figures\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Alzheimer\u2019s Association<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.alz.co.uk\/research\/WorldAlzheimerReport2018.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Alzheimer\u2019s Association<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-018-0348-0\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">BioMedCentral<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/edition.cnn.com\/2019\/09\/17\/health\/alzheimers-aerobic-exercise-wellness\/index.html\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">CNN<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.jhsph.edu\/news\/news-releases\/2002\/alzheimer-age.html\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">JHSPH<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.medicalnewstoday.com\/articles\/159442#causes\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Medical News Today<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6197734\/pdf\/main.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCBI<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4356853\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCBI<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4619185\/pdf\/nihms-696749.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCBI<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"http:\/\/www.scielo.br\/pdf\/dn\/v5n4\/1980-5764-dn-5-04-00328.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">SciELO<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.sciencedaily.com\/releases\/2017\/02\/170210085532.htm\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Science Daily<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.sciencedaily.com\/releases\/2017\/04\/170410085020.htm\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Science Daily<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.sciencedaily.com\/releases\/2017\/05\/170531092607.htm\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Science Daily<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.sciencedaily.com\/releases\/2007\/06\/070627161810.htm\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Science Daily<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1552526019300317\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Science Direct<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1552526019300317#bib51\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Science Direct<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.statista.com\/statistics\/452934\/projected-number-of-people-65-years-and-older-with-alzheimers-disease-in-us-by-state\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Statista<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.statista.com\/statistics\/311941\/top-ten-causes-of-death-in-upper-income-countries\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Statista<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.statista.com\/statistics\/248622\/rates-of-leading-causes-of-death-in-the-us\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Statista<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.statista.com\/statistics\/1020258\/dementia-deaths-us-number\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Statista<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.statista.com\/statistics\/216640\/leading-us-states-by-alzheimers-mortality-rate\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Statista<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.statista.com\/statistics\/216620\/estimated-lifetime-risks-for-alzheimers-by-age-and-gender\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Statista<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.statista.com\/statistics\/216673\/alzheimer-and-dementia-caregivers-unpaid-care-in-the-us\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Statista<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.statista.com\/statistics\/492620\/residential-care-residents-diagnosed-medical-conditions-community-size\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Statista<\/span><\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>For more than a century, scientists have been struggling to understand the exact causes of [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":1881,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_jetpack_memberships_contains_paid_content":false},"categories":[133,134],"tags":[149,151,146,148,152],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/healthcareers.co\/wp-content\/uploads\/2020\/04\/steven-hwg-zBsdRTHIIm4-unsplash.jpg","_links":{"self":[{"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/posts\/1880"}],"collection":[{"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/comments?post=1880"}],"version-history":[{"count":2,"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/posts\/1880\/revisions"}],"predecessor-version":[{"id":2665,"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/posts\/1880\/revisions\/2665"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/media\/1881"}],"wp:attachment":[{"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/media?parent=1880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/categories?post=1880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/healthcareers.co\/wp-json\/wp\/v2\/tags?post=1880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}